CRSP - Crispr Therapeutics AG - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRSP is currently covered by 17 analysts with an average price target of $68.5. This is a potential upside of $21.24 (44.94%) from yesterday's end of day stock price of $47.26.

Crispr Therapeutics AG's activity chart (see below) currently has 202 price targets and 193 ratings on display. The stock rating distribution of CRSP is 27.78% HOLD, 63.89% BUY and 8.33% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.75% with an average time for these price targets to be met of 97.81 days.

Highest price target for CRSP is $160, Lowest price target is $30, average price target is $68.5.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 06-Nov-2024. First documented stock forecast 15-Nov-2016.

Currently out of the existing stock ratings of CRSP, 20 are a HOLD (27.78%), 46 are a BUY (63.89%), 6 are a SELL (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$55

$7.75 (16.40%)

$59

14 days ago
(06-Nov-2024)

9/15 (60%)

$4.81 (9.58%)

109

Buy

$84

$36.75 (77.78%)

$84

14 days ago
(06-Nov-2024)

8/16 (50%)

$33.81 (67.36%)

214

Hold

$53

$5.75 (12.17%)

$53

14 days ago
(06-Nov-2024)

9/11 (81.82%)

$2.81 (5.60%)

180

Hold

$59

$11.75 (24.87%)

$64

3 months 14 days ago
(06-Aug-2024)

6/8 (75%)

$9.67 (19.60%)

38

Buy

$94

$46.75 (98.94%)

$112

3 months 14 days ago
(06-Aug-2024)

3/11 (27.27%)

$44.67 (90.55%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?

On average it took 97.81 days on average for the stock forecasts to be realized with a an average price target met ratio 63.75

Which analyst has the current highest performing score on CRSP (Crispr Therapeutics AG) with a proven track record?

JAMES LEE

Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?

James Lee works at MIZUHO and has 38 price targets and 24 ratings on CRSP

Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?

Salveen Richter with highest potential upside - $141.75

Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?

Tyler Van Buren with lowest potential downside - -$17.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?